Cellecor Gadgets Limited

NSEI:CELLECOR Stok Raporu

Piyasa değeri: ₹12.7b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Cellecor Gadgets Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Cellecor Gadgets has a total shareholder equity of ₹899.4M and total debt of ₹747.4M, which brings its debt-to-equity ratio to 83.1%. Its total assets and total liabilities are ₹1.9B and ₹959.1M respectively. Cellecor Gadgets's EBIT is ₹291.8M making its interest coverage ratio 3.9. It has cash and short-term investments of ₹44.5M.

Anahtar bilgiler

83.1%

Borç/özkaynak oranı

₹747.44m

Borç

Faiz karşılama oranı3.9x
Nakit₹44.47m
Eşitlik₹899.37m
Toplam yükümlülükler₹959.13m
Toplam varlıklar₹1.86b

Son finansal sağlık güncellemeleri

Recent updates

Optimistic Investors Push Cellecor Gadgets Limited (NSE:CELLECOR) Shares Up 27% But Growth Is Lacking

Aug 21
Optimistic Investors Push Cellecor Gadgets Limited (NSE:CELLECOR) Shares Up 27% But Growth Is Lacking

Cellecor Gadgets Limited's (NSE:CELLECOR) 26% Share Price Surge Not Quite Adding Up

Jun 27
Cellecor Gadgets Limited's (NSE:CELLECOR) 26% Share Price Surge Not Quite Adding Up

Here's Why Cellecor Gadgets (NSE:CELLECOR) Can Manage Its Debt Responsibly

Jun 20
Here's Why Cellecor Gadgets (NSE:CELLECOR) Can Manage Its Debt Responsibly

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CELLECOR's short term assets (₹1.8B) exceed its short term liabilities (₹954.7M).

Uzun Vadeli Yükümlülükler: CELLECOR's short term assets (₹1.8B) exceed its long term liabilities (₹4.5M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CELLECOR's net debt to equity ratio (78.2%) is considered high.

Borcun Azaltılması: Insufficient data to determine if CELLECOR's debt to equity ratio has reduced over the past 5 years.

Borç Kapsamı: CELLECOR's operating cash flow is negative, therefore debt is not well covered.

Faiz Kapsamı: CELLECOR's interest payments on its debt are well covered by EBIT (3.9x coverage).


Bilanço


Sağlıklı şirketleri keşfedin